Literature DB >> 26334724

Cannabinoids in the Treatment of Neurological Disorders.

Orrin Devinsky1, Benjamin J Whalley2, Vincenzo Di Marzo3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26334724      PMCID： PMC4604187          DOI： 10.1007/s13311-015-0388-0

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN： 1878-7479            Impact factor:   7.620


× No keyword cloud information.
  8 in total

Review 1.  Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.

Authors:  John M McPartland; Marnie Duncan; Vincenzo Di Marzo; Roger G Pertwee
Journal:  Br J Pharmacol       Date:  2015-02       Impact factor: 8.739

2.  Hashish. I. The structure of cannabidiol.

Authors:  R Mechoulam; Y Shvo
Journal:  Tetrahedron       Date:  1963-12       Impact factor: 2.457

Review 3.  THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis.

Authors:  Jaume Sastre-Garriga; Carlos Vila; Stephen Clissold; Xavier Montalban
Journal:  Expert Rev Neurother       Date:  2011-04-01       Impact factor: 4.618

Review 4.  Medical marijuana for cancer.

Authors:  Joan L Kramer
Journal:  CA Cancer J Clin       Date:  2014-12-10       Impact factor: 508.702

Review 5.  The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

Review 6.  Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.

Authors:  Roger G Pertwee
Journal:  Addict Biol       Date:  2008-06       Impact factor: 4.280

7.  Marihuana: Tetrahydrocannabinol and Related Compounds.

Authors:  M Lerner
Journal:  Science       Date:  1963-04-12       Impact factor: 47.728

Review 8.  Endocannabinoid signaling at the periphery: 50 years after THC.

Authors:  Mauro Maccarrone; Itai Bab; Tamás Bíró; Guy A Cabral; Sudhansu K Dey; Vincenzo Di Marzo; Justin C Konje; George Kunos; Raphael Mechoulam; Pal Pacher; Keith A Sharkey; Andreas Zimmer
Journal:  Trends Pharmacol Sci       Date:  2015-03-18       Impact factor: 14.819
  8 in total
  3 in total

1.  Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPARγ Agonist via a Combined Computational and Functional Study.

Authors:  Fabio Arturo Iannotti; Fabrizia De Maio; Elisabetta Panza; Giovanni Appendino; Orazio Taglialatela-Scafati; Luciano De Petrocellis; Pietro Amodeo; Rosa Maria Vitale
Journal:  Molecules       Date:  2020-03-03       Impact factor: 4.411

Review 2.  Medical cannabis and cannabidiol: A new harvest for Malawi.

Authors:  Gama Bandawe
Journal:  Malawi Med J       Date:  2022-06       Impact factor: 1.413

3.  Species-specific susceptibility to cannabis-induced convulsions.

Authors:  Benjamin J Whalley; Hong Lin; Lynne Bell; Thomas Hill; Amesha Patel; Roy A Gray; C Elizabeth Roberts; Orrin Devinsky; Michael Bazelot; Claire M Williams; Gary J Stephens
Journal:  Br J Pharmacol       Date:  2018-03-25       Impact factor: 8.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.